A. Spanevello (Cassano Murge (Ba), Italy), R. Taylor (Dunedin, New Zealand)
Introduction “Never say no: current trends in asthma phenotyping”
I. Horvath (Budapest, Hungary)
|  |
Is DawNO a new measurement to characterise allergic and non-allergic asthma?
M. Högman, A. Malinovschi, D. Norbäck, C. Janson (Gävle, Uppsala, Sweden)
|   |
Exhaled nitric oxide threshold to predict sputum eosinophils count ≥3% in a cohort of unselected asthmatics
F. Schleich, M. Henket, J. Sele, M. Manise, V. Quaedvlieg, A. Michils, R. Louis (Liege, Brussel, Belgium)
| |
Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study
K. Kostikas, A. Papaioannou, K. Tanou, A. Giouleka, A. Koutsokera, M. Minas, S. Papiris, K. Gourgoulianis, S. Loukides (Larissa, Athens, Greece)
| |
Oral steroid intervention in severe asthma: focus on phenotypes. Report from the bioair study
R. Middelveld, M. Kupczyk, S. E. Dahlén, BIOAIR (Stockholm, Sweden)
| |
Exhaled nitric oxid in pregnant healthy and asthmatic women
L. Tamási, A. Bohács, A. Bikov, J. Rigó, Jr., G. Losonczy, P. Magyar, I. Horváth (Budapest, Hungary)
| |
Menopausal asthma: a new biological phenotype?
G. E. Carpagnano, C. Ruggeri, L. Bergantino, A. Spanevello, G. P. Palladino, M. G. Cagnazzo, O. Resta, R. Urbano, M. P. Foschino Barbaro, V. Turchiarelli, A. Depalo, R. Sabato (Foggia, Bari, Italy)
| |
Metabolic acidosis improves airway conductance in patients with asthma
F. Brijker, F. van den Elshout, F. Bosch, Y. Heijdra, H. Folgering (Utrecht, Arnhem, Groesbeek, Netherlands)
| |